Diabetes mellitus increases risk of unsuccessful graft preparation in descemet membrane endothelial keratoplasty: A multicenter study

Cornea

Volumn 33, Issue 11, 2014, Pages 1129-1133

  Greiner, Mark A ^a,b   Rixen, Jordan J ^a   Wagoner, Michael D ^a,b   Schmidt, Gregory A ^a   Stoeger, Christopher G ^c   Straiko, Michael D ^d   Zimmerman, M Bridget ^a   Kitzmann, Anna S ^a,b   Goins, Kenneth M ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b Iowa Lions Eye Bank   (United States)

^c Lions VisionGift Research   (United States)

^d DEVERS EYE INSTITUTE   (United States)

Author keywords

Corneal edema; Descemet membrane endothelial keratoplasty; Diabetes mellitus; Eye banking

Indexed keywords

AGED; ARTICLE; CELL DENSITY; CONTROLLED STUDY; CORNEA; DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY; DIABETES MELLITUS; DONOR; ENDOTHELIUM CELL; EYEBANK; GRAFT FAILURE; HUMAN; HUMAN TISSUE; MULTICENTER STUDY; PRIORITY JOURNAL; TISSUE PREPARATION; CLINICAL TRIAL; CORNEA ENDOTHELIUM; DESCEMET MEMBRANE; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; FEMALE; GRAFT SURVIVAL; LABORATORY DIAGNOSIS; MALE; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; DESCEMET MEMBRANE; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DIABETES COMPLICATIONS; DIABETES MELLITUS; ENDOTHELIUM, CORNEAL; EYE BANKS; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SPECIMEN HANDLING; TISSUE DONORS;

EID: 84924159333     PISSN: 02773740     EISSN: 15364798     Source Type: Journal    
DOI: 10.1097/ICO.0000000000000262     Document Type: Article

References (25)

1. Dapena I, Ham L, Droutsas K, et al. Learning curve in Descemet's membrane endothelial keratoplasty: first series of 135 consecutive cases. Ophthalmology. 2011;118:2147-2154.
2. Dirisamer M, Ham L, Dapena I, et al. Efficacy of Descemet membrane endothelial keratoplasty: clinical outcome of 200 consecutive cases after a learning curve of 25 cases. Arch Ophthalmol. 2011;129:1435-1443.
3. Eye Bank Association of America. 2013 Eye Banking Statistical Report. Washington, DC: Eye Bank Association of America; 2013.
4. Guerra FP, Anshu A, Price MO, et al. Descemet's membrane endothelial keratoplasty: prospective study of 1-year visual outcomes, graft survival, and endothelial cell loss. Ophthalmology. 2011;118:2368-2373.
5. Price MO, Giebel AW, Fairchild KM, et al. Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009;116: 2361-2368.
6. Tourtas T, Laaser K, Bachmann BO, et al. Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012;153:1082.e2-1090.e2.
7. Kruse FE, Laaser K, Cursiefen C, et al. A stepwise approach to donor preparation and insertion increases safety and outcome of Descemet membrane endothelial keratoplasty. Cornea. 2011;30:580-587.
8. Lie JT, Birbal R, Ham L, et al. Donor tissue preparation for Descemet membrane endothelial keratoplasty. J Cataract Refract Surg. 2008;34: 1578-1583.
9. Melles GR, Ong TS, Ververs B, et al. Descemet membrane endothelial keratoplasty (DMEK). Cornea. 2006;25:987-990.
10. Terry MA. Endothelial keratoplasty: why aren't we all doing Descemet membrane endothelial keratoplasty? Cornea. 2012;31:469-471.
11. Cursiefen C. Descemet membrane endothelial keratoplasty: The taming of the shrew. JAMA Ophthalmol. 2013;131:88-89.
12. Hanley JA, Negassa A, Edwardes MD, et al. Statistical analysis of correlated data using generalized estimating equations: An orientation. Am J Epidemiol. 2003;157:364-375.
13. Rosner B, Milton RC. Significance testing for correlated binary outcome data. Biometrics. 1988;44:505-512.
14. Brownlee M, Vlassara H, Cerami A. Nonenzymatic glycosylation and the pathogenesis of diabetic complications. Ann Intern Med. 1984;101: 527-537.
15. Stitt AW. Advanced glycation: An important pathological event in diabetic and age related ocular disease. Br J Ophthalmol. 2001;85:746-753.
16. Kaji Y, Usui T, Oshika T, et al. Advanced glycation end products in diabetic corneas. Invest Ophthalmol Vis Sci. 2000;41:362-368.
17. Sady C, Khosrof S, Nagaraj R. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes. Biochem Biophys Res Commun. 1995;214:793-797.
18. Johnson DH, Bourne WM, Campbell RJ. The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas. Arch Ophthalmol. 1982;100:1942-1947.
19. Levy SG, McCartney AC, Moss J. The distribution of fibronectin and P component in Descemet's membrane: An immunoelectron microscopic study. Curr Eye Res. 1995;14:865-870.
20. Murphy C, Alvarado J, Juster R. Prenatal and postnatal growth of the human Descemet's membrane. Invest Ophthalmol Vis Sci. 1984;25: 1402-1415.
21. Schlötzer-Schrehardt U, Bachmann BO, Laaser K, et al. Characterization of the cleavage plane in DESCemet's membrane endothelial keratoplasty. Ophthalmology. 2011;118:1950-1957.
22. Schlötzer-Schrehardt U, Bachmann BO, Tourtas T, et al. Reproducibility of graft preparations in Descemet's membrane endothelial keratoplasty. Ophthalmology. 2013;120:1769-1777.
23. Akimoto Y, Sawada H, Ohara-Imaizumi M, et al. Change in longspacing collagen in Descemet's membrane of diabetic Goto-Kakizaki rats and its suppression by antidiabetic agents. Exp Diabetes Res. 2008;2008:818341.
24. Latour G, Kowalczuk L, Savoldelli M, et al. Hyperglycemia-induced abnormalities in rat and human corneas: The potential of second harmonic generation microscopy. PLoS One. 2012;7:e48388.
25. Centers for Disease Control and Prevention. Diabetes data & trends. Available at: http://apps.nccd.cdc.gov/DDTSTRS/default.aspx. Accessed December 7, 2013.